Takeda’s phase-III Panther trial unable to achieve primary endpoint of event-free survival
The trial evaluated whether the combination of pevonedistat plus azacitidine as first-line treatment for patients with higher-risk…
Recover your password.
A password will be e-mailed to you.
Recover your password.
A password will be e-mailed to you.